Esmaeel Babaeenezhad

Dr. Esmaeel Babaeenezhad

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 January 2021 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
EBEsmaeel Babaeenezhad
Esmaeel Babaeenezhad
FMForouzan Hadipour Moradi
Forouzan Hadipour Moradi
SMSobhan Rahimi Monfared
Sobhan Rahimi Monfared
MFMohammad Davood Fattahi
Mohammad Davood Fattahi
MNMaryam Nasri
Maryam Nasri
HAHassan Ahmadvand
Hassan Ahmadvand
Clinical application of gentamicin (GM) is well known to be associated with the development of acute kidney injury (AKI). This study was the first to investigate the possible protective effects of D‐limonene (D‐lim) on AKI following GM administration in rats. 32 rats arranged in four groups (n = 8): (1) the control group received saline intraperitoneally (0.5 ml/day) and orally (0.5 ml/day), (2) the D‐lim group received D‐lim (100 mg/kg) orally and saline (0.5 ml/day) intraperitoneally, (3) the GM group received GM (100 mg/kg/day) intraperitoneally and saline (0.5 ml/day) orally, and (4) the treated group received intraperitoneal GM (100 mg/kg) and oral D‐lim (100 mg/kg). All treatments were performed daily for 12 consecutive days. Results revealed that D‐lim ameliorated GM‐induced AKI, oxidative stress, mitochondrial apoptosis, and inflammation. D‐lim showed nephroprotective effects as reflected by the decrease in serum urea and creatinine and improvement of renal histopathological changes. D‐lim alleviated GM‐induced oxidative stress by increasing the activities of renal catalase, serum and renal glutathione peroxidase, and renal superoxide dismutase and decreasing renal malondialdehyde and serum nitric oxide levels. Intriguingly, D‐lim suppressed mitochondrial apoptosis by considerably downregulating Bax and caspase‐3 (Casp‐3) mRNA and protein expressions and markedly enhancing Bcl2 mRNA and protein expressions. Furthermore, D‐lim significantly decreases GM‐induced inflammatory response through downregulation of NF‐κB, IL‐6, and TNF‐α mRNA and/or protein expressions and decrease in renal myeloperoxidase activity. Finally, D‐lim remarkably downregulated PCNA protein expression in the treated group compared with the GM group. In brief, this study showed that D‐lim alleviated AKI following GM administration in rats, partially through its antioxidant, anti‐inflammatory, and antiapoptotic activities as well as downregulation of PCNA expression.

6 December 2024 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MRMarzieh Rashidipour
Marzieh Rashidipour
SASaber Abbaszadeh
Saber Abbaszadeh
MBMehdi Birjandi
Mehdi Birjandi
NPNaser Pajouhi
Naser Pajouhi
SSShahram Ahmadi Somaghian
Shahram Ahmadi Somaghian
EBEsmaeel Babaeenezhad
Esmaeel Babaeenezhad
Tannic acid (TA) is a potent antitumor agent, but its low bioavailability and absorption limit its use. In this study, it was loaded into chitosan-based nanoparticles (Chi-NPs) to overcome these limitations and to improve its antimicrobial and anticancer activities. TA-loaded Chi-NPs (Chi-TA-NPs) were synthesized using the ionic gelation method and physicochemically characterized by FE-SEM, FTIR, XRD, PDI, DLS, and zeta potential analysis. Additionally, the antimicrobial activity of Chi-TA-NPs against two G+ bacterial strains, two G− bacterial strains, and a fungal strain (Candida albicans) was investigated using the microbroth dilution method. MTT assay was used to examine the cytotoxic effects of Chi-TA-NPs on HepG2 cells. The expression of DNA methyltransferase 1 (DNMT1), DNMT3A, and DNMT3B was examined in HepG2 cells using RT-qPCR. The amount of 5-methylcytosine in the HepG2 cell-derived genomic DNA was measured using ELISA. FE-SEM micrographs showed the loading of TA into the chitosan-based formulation. The peaks detected in the XRD and FTIR analyses confirmed the formation of the Chi-TA-NPs. The PDI value (0.247 ± 0.03), size (567.0 ± 25.84 nm), and zeta potential (17.0 ± 5.86 mV) confirmed the relative stability of Chi-TA-NPs. A constant release profile in line with the Korsmeyer-Peppas model was detected for Chi-TA-NPs, such that approximately 44% of TA was released after 300 min. In addition, Chi-TA-NPs exhibited effective antimicrobial activity against the studied microbial strains, as manifested by MIC values ranging from 250 to 1000 µg/mL. Chi-TA-NPs induced cytotoxicity in liver tumor cell line, with an IC50 value of 500 µg/mL. Furthermore, Chi-TA-NPs considerably decreased the expression of DNMT1 (2.52-fold; p = 0.01), DNMT3A (2.96-fold; p = 0.004), and DNMT3B (2.94-fold; p < 0.0001). However, 5-methylcytosine levels in HepG2 cells were unaffected by Chi-TA-NPs treatment (p = 0.62). Finally, the antimicrobial, cytotoxic, and epigenetic effects of Chi-TA-NPs were more pronounced than those of free TA and the unloaded Chi-NPs. In conclusion, Chi-TA-NPs exhibit promising potential for reducing microbial growth and promoting cytotoxicity in liver cancer cells.

23 August 2018 in Journal of Renal Injury Prevention
Verified
Journal Article
Open access
PDF file
HAHassan Ahmadvand
Hassan Ahmadvand
EBEsmaeel Babaeenezhad
Esmaeel Babaeenezhad
MNMaryam Nasri
Maryam Nasri
LJLeila Jafaripour
Leila Jafaripour
RKReza Mohammadrezaei Khorramabadi
Reza Mohammadrezaei Khorramabadi
Introduction: Glutathione (GSH) protects the tissue and cell from oxidative injury. Objectives: In the current study, we investigated the possible effects of GSH on liver markers, oxidative stress and inflammatory indices in rat with renal ischemia reperfusion (RIR) injury. Materials and Methods: Twenty-four adult male Wistar rats were divided into 3 groups (n=8). Group I (the control group), group II (the RIR group) received saline (0.25 mL/d, intraperitoneally; i.p.), group III as the RIR group that received GSH (100 mg/kg/d, i.p.). The treatment with saline or GSH began daily 14 days before RIR induction. RIR was induced by clamping renal pedicles for 45 minutes and 24 hours of reperfusion. Results: RIR significantly increased the serum level of nitric oxide (NO), the serum activities of aspartate aminotransferase (AST), alkaline phosphatase (ALP), gamma-glutamyltransferase (GGT), the serum and renal levels of malondialdehyde (MDA), and the serum activity of myeloperoxidase (MPO). However, RIR significantly decreased the serum and renal levels of GSH, serum paraoxonase 1 (PON1) activity, and the serum and renal activities of catalase (CAT) and glutathione peroxidase (GPX). GSH administration could significantly improve the serum activities of AST, GGT, MPO, GPX and PON1 and serum levels of NO, renal MDA, GSH levels, and serum and also renal CAT activities. Conclusion: Our study indicated that GSH administration ameliorated RIR injury in rats by improving the activities of liver markers and antioxidant enzymes, the levels of MDA, NO, GSH and MPO activity.

1 January 2020 in Brazilian Archives of Biology and Technology
Verified
Journal Article
Open access
PDF file
HAHassan Ahmadvand
Hassan Ahmadvand
NNnegar nouryazdan
negar nouryazdan
MNMaryam Nasri
Maryam Nasri
GAGlavizh Adibhesami
Glavizh Adibhesami
EBEsmaeel Babaeenezhad
Esmaeel Babaeenezhad
Gallic acid (GA), as a strong antioxidant, was selected in this study to investigate its possible nephroprotective effects against gentamicin (GM)-induced nephrotoxicity. Twenty-four rats were separated into three groups (n=8): group 1 (control group) received saline (0.5 mL/day), group 2 (GM group) received GM (100 mg/kg/day), and group 3 (treated group) received GM (100 mg/kg/day) and GA (100mg/kg/day). All treatments were performed intraperitoneally for 12 days. After 12 days, the rats were euthanized, and kidneys were removed immediately. For serum preparation, blood samples were collected before killing. Kidney paraffin sections were prepared from one of the kidneys and stained by the periodic acid-Schiff process. GA significantly decreased GM-induced renal histopathological injuries, including tubular necrosis, tubular cast, and leucocyte infiltration compared with the GM group. Additionally, GA significantly improved proteinuria, serum levels of urea and creatinine, and serum activities of aspartate aminotransferase (AST) and alanine aminotransferase (ALT) compared with nephrotoxic animals. Furthermore, GA caused a significant improvement in the levels of cholesterol (Chol), low-density lipoprotein (LDL), high-density lipoprotein (HDL), and cardiac risk ratios 1 and 2 in comparison with nephrotoxic animals. GA administration was observed to significantly improve the levels of lipid peroxidation, nitric oxide (NO), and glutathione (GSH) compared with the GM group. Finally, the activities and gene expression levels of catalase (CAT) and glutathione peroxidase (GPX) significantly increased following GA administration compared with the GM group. Our results indicated that GA has potential protective effects against GM nephrotoxicity by reducing oxidative stress in rats.

1 April 2019
Verified
Journal Article
Closed access
MCMostafa Cheraghi
Mostafa Cheraghi
HAHassan Ahmadvand
Hassan Ahmadvand
Ali MalekiAli Maleki
Ali Maleki
EBEsmaeel Babaeenezhad
Esmaeel Babaeenezhad
SSSalman Shakiba
Salman Shakiba
FHFatemeh Hassanzadeh
Fatemeh Hassanzadeh

8 October 2022 in Non-Coding RNA
Verified
Journal Article
Open access
PDF file
EBEsmaeel Babaeenezhad
Esmaeel Babaeenezhad
FNFakhraddin Naghibalhossaini
Fakhraddin Naghibalhossaini
MRMasoumeh Rajabibazl
Masoumeh Rajabibazl
ZJzohreh jangravi
zohreh jangravi
FMForouzan Hadipour Moradi
Forouzan Hadipour Moradi
SSSoroosh Shahryarhesami
Soroosh Shahryarhesami
Digestive tract cancers represent a serious public health issue. In recent years, evidence has accumulated that microRNA miR-185 is implicated in the pathogenesis of this group of highly malignant tumors. Its expression variations correlate with clinical features, such as tumor size, lymph node metastasis, tumor node metastatic stage, survival, recurrence and response to adjuvant therapy, and have diagnostic and prognostic potential. In this review, we compile, evaluate and discuss the current knowledge about the roles of miR-185 in digestive tract cancers. Interestingly, miR-185 is apparently involved in regulating both tumor suppressive and oncogenic processes. We look at downstream effects as well as upstream regulation. In addition, we discuss the utility of miR-185 for diagnosis and its potential concerning novel therapeutic approaches.